Your site has given me a lot of hope as well as key useful information.~Patient Power survey respondent
Is diversity, gender, age and ethnicity important in clinical trials? Mel Mann, a 20+ year CML survivor and a a highly respected leader in the field of clinical oncology weigh in.
Published:
Can lung cancer patients attending medical meetings bring about real change in the science? Hear from a lung cancer researcher, patient advocate and care partner.
Published:
In this MythBusters program, patient advocate Jim Omel and Dr. Michael Thompson examine barriers patients may face and discuss the safety and quality of clinical trial care. Does the process need a makeover? Watch now to find out more.
Published:
